Lan Bo Chen
29Patents
6h-index
36Co-inventors
69Inventor score
Filing activity: Apr 2, 1987 → Jan 7, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5169788A | Methods of measuring membrane potential using J-aggregate forming dyes | Emerging Cross-Sectional Technologies | 21 | Expired |
| US5670530A | Anti-cancer composition comprising rhodacyanine compound and cyclodextrin | Performing Operations; Transporting | 10 | Expired |
| US6541062B2 | Water-soluble soybean extracts | Human Necessities | 8 | Expired |
| US5360803A | Composition and method for treating cancer | Human Necessities | 8 | Expired |
| US5872235A | Nucleic acids encoding tumor marker | Chemistry; Metallurgy | 7 | Expired |
| US5196413A | Platinum complexes and the like | Chemistry; Metallurgy | 6 | Expired |
| US7087727B2 | Periostin-based diagnostic assays | Physics | 6 | Expired |
| US6458406B1 | Water-soluble bean-based extracts | Human Necessities | 5 | Expired |
| US6303157A | Extracts of kava-kava | Human Necessities | 4 | Expired |
| US4774250A | Composition and method for treating differentiated carcinoma or melanoma cells with thiapyrylium dyes | Human Necessities | 3 | Expired |
| US5618831A | Composition and method for treating cancer | Human Necessities | 3 | Expired |
| US5843737A | Cancer associated gene protein expressed therefrom and uses thereof | Human Necessities | 3 | Expired |
| US5889159A | Monoclonal antibodies to tumor marker TC1 and methods for use of same | Chemistry; Metallurgy | 2 | Expired |
| US4921973A | Platinum complexes and the like | Chemistry; Metallurgy | 2 | Expired |
| US5861424A | Composition and method for treating cancer | Human Necessities | 2 | Expired |
| US10919977B2 | Bispecific tetravalent antibodies and methods of making and using thereof | Chemistry; Metallurgy | 2 | Active |
| US6616959B2 | Water-soluble bean-based extracts | Human Necessities | 2 | Expired |
| US7182972B2 | Water-soluble bean-based extracts | Human Necessities | 2 | Expired |
| US11045496B2 | Adoptive cell transfer and oncolytic virus combination therapy | Chemistry; Metallurgy | 1 | Active |
| US10688182B2 | Monoclonal antibodies that bind to SSEA4 and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10751399B2 | Chimeric antigen receptors that bind to SSEA4 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7638272B2 | Cancer therapy sensitizer | Human Necessities | 0 | Expired |
| US11628210B2 | Chimeric antigen receptors that bind to SSEA4 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US6537592B2 | Extracts of kava-kava | Human Necessities | 0 | Expired |
| US8071294B2 | Cancer therapy sensitizer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.